Bioanalysis is integral throughout all stages of drug development, including candidate screening, mechanism ofaction characterization, safety assessment as well as potency, stability and comparability studies duringmanufacturing. Canton Biologics has extensive expertise in functional and potency bioassays for a variety ofbiotherapeutic modalities-Such as antibodies, vaccines ADCs, and fusion proteinsdelivering comprehensivebioanalytical services to our clients.Our team possesses substantial project experience in cell-based activity assays, selecting relevant target oreffector cells based on the specific drug's mechanism of action and developing corresponding cell-based potencymethods. We offer a range of bioanalytical approaches, including assessment of target-effector cell binding, signaltransduction, cell proliferation, cytotoxicity, viral neutralization, cytokine release, and other immune functionanalysesAdditionally, we provide custom assay development and validation-including reporter cell line engineering-tosupport feasibility studies, IND submissions, non-clinical and clinical studies. All services are performed incompliance with current bioanalytical guidelines from NMPA, ICH, FDA, and EMA, ensuring high-quality data toadvance our clients' programs.